Summit Therapeutics PLC said Erik Ostrowski would step down as CFO at the end of December.

"The company will appoint a new chief financial officer in due course," Summit Therapeutics said.

Abingdon, U.K.-based Summit Therapeutics is a biopharmaceutical company that focuses on the discovery, development and commercialization of novel medicines to treat rare and infectious diseases.